Crossmark

Expressional profiling and clinical relevance of RNase κ in prostate cancer: a novel indicator of favorable progression-free survival

Crossref DOI link: https://doi.org/10.1007/s00432-018-2719-0

Published Online: 2018-07-27

Published Print: 2018-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Kladi-Skandali, Athina

Mavridis, Konstantinos

Scorilas, Andreas

Sideris, Diamantis C. https://orcid.org/0000-0001-6518-0098
License Information

Text and Data Mining valid from 2018-07-27
More Information

Article History

Received: 12 March 2018

Accepted: 19 July 2018

First Online: 27 July 2018

Compliance with Ethical Standards

:

: The authors declare that they have no conflict of interest.

: All research procedures that took place during the completion of our study comply with the ethical standards of the 1975 Declaration of Helsinki, as revised in 2008, and were approved by the institutional review board of ‘Saint Savvas’ Anticancer Hospital. Additionally, written informed consent was obtained from all BC patients participating in the study.